The Transgenic Mouse Service (TMS) creates transgenic mice
by pronuclear injection of (C57BL/6J X SJL/J) F2 embryos with transgenic
expression cassettes prepared by investigators.
Creating a transgenic mouse requires several critical steps.
- Designing an effective transgenic expression cassette
- Purifying high quality DNA for pronuclear microinjection
- Successful pronuclear microinjection and embryo transfer
- Genotyping of mouse tail biopsies to identify potential founder
mice
- Breeding of founders to establish the transgenic line
Each of these steps requires coordination between investigators
and the TMS. Please read the following information before submitting
your construct:
Transgenic expression cassettes
Transgenic expression cassettes that use genomic DNA rather than
cDNA are generally more efficiently expressed in mice. Consider
including generic introns when cDNA is used and levels of expression
are important. Select promoter sequences with proven tissue specific
expression in transgenic mice where possible.
BACK TO TOP
Proper purification of transgenic expression cassettes
Proper purification of transgenic expression cassettes is crucial
for successful transgenic mouse production. Mouse embryos are highly
susceptible to trace contaminants such as phenol, ethanol, endotoxin,
and enzymes. In addition, particulates obstruct microinjection pipettes.
The number of live births from microinjected embryos is a direct
function of the purity of the DNA being microinjected. Transgenic
expression cassettes must be excised from highly purified plasmids,
isolated by sucrose gradient centrifugation or electrophoresis followed
by electroelution, and the linearized isolated fragments further
purified using one of several protocols.
If DNA submitted is deemed to be inferior based on results of pronuclear
injection and embryo transfer, the investigator will be charged
and asked to submit a new sample.
BACK TO TOP
BAC Transgenics
The TMS will microinject BAC DNA to create the desired transgenic mice. However, due to
the size of such constructs, the time between submission and microinjection of the DNA presents
a potential problem for stability of the BAC DNA during storage. In addition, high purity of
the DNA is absolutely critical but tricky to achieve; extra care must be exercised in order to
prepare BAC DNA that can be microinjected. With these factors in mind, the TMS recommends that
prior to construct preparation, users refer to the website of the University of Michigan Transgenic Animal Model Core for protocols for DNA preparation and storage. In particular, note the use of
polyamine buffer for “long-term” storage of purified BAC DNA that may obviate the need to submit DNA
that is prepared within 24 hrs. of microinjection. In addition, one of our Yale users, Dan Kaplan,
recommends that if a gel is used to purify the BAC, the molten agar should be filtered through a 0.22uM
filter prior to casting to remove impurities that may block microinjection needles and prevent the DNA
from being microinjected. The problem of DNA stability causes problems with scheduling of BAC
microinjection. Due to the need to schedule microinjection dates in advance (as opposed to adding
the construct to the queue of traditional constructs), and the corresponding need to order the
appropriate mice, carefully prepared DNA must be submitted to TMS as scheduled. If such a scheduled
arrangement is necessary, and the investigator is unable to submit the DNA as planned, the investigator
will be charged for the mice ordered and used for that date.
Pronuclear microinjection
Pronuclear microinjection of approximately 250 embryos of (C57BL/6J
X SJL/J) F2 mice is performed typically over four days; 200 to 250
are transferred to the uteri of six pseudopregnant foster mothers.
Litters are maintained by the TMS pending results of tail genotyping.
Genotyping mice
Investigators are provided tail biopsies from individually identified
weanling mice six weeks after embryo microinjections are completed.
Investigators extract DNA from tail biopsies using established protocols
and identify individuals with integrated sequences by polymerase
chain reaction (PCR) analysis or Southern blot analysis. After positive
mice are identified, an animal relocation
request form is completed so that mice can be transferred to
the investigators animal room(s).
Breeding transgenic mice
Potential founder mice become the property of the investigator
who may wish to obtain additional advice and services related to
breeding from the YARC Rodent Service. Animals that test positive
for integration of transgenes may have copies in all somatic and
germ cells or may be mosaic. It is important to note that integration
into the genome is random so that each transgenic animal is uniquely
hemizygous. The genome of each potential founder must be reiterated
by mating with non-transgenic mice to demonstrate germline transmission
and to select hemizygous individuals for intercrossing to produce
homozygous transgenic lines.
YARC
Rodent Service
Transgenic Mouse Service Order
Form
Contact James McGrath,
M.D., Ph.D. (785-2686) or Carole
Pease (785-6923).
|